OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+0.42%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$116M
AUM Growth
+$116M
(-25%)
Cap. Flow
-$33.8M
Cap. Flow
% of AUM
-29.24%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
14
New
–
Increased
1
Reduced
3
Closed
2
Top Buys
| 1 |
Biohaven
BHVN
|
$102K |
Top Sells
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$23.4M |
| 2 |
GeneDx Holdings
WGS
|
$4.38M |
| 3 |
Ardelyx
ARDX
|
$3.82M |
| 4 |
Teladoc Health
TDOC
|
$1.61M |
| 5 |
Recursion Pharmaceuticals
RXRX
|
$635K |
Sector Composition
| 1 | Healthcare | 95.16% |
| 2 | Technology | 3.48% |
| 3 | Consumer Discretionary | 1.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
GeneDx Holdings
WGS
$3.72B
| $85.2M | 58.4% |
922,454
-47,500
| -5% | -$4.38M |
|
|
2
Biohaven
BHVN
$1.63B
| $9.5M | 6.51% |
673,166
+7,221
| +1% | +$102K |
|
|
3
Ardelyx
ARDX
$1.53B
| $5.61M | 3.85% |
1,430,728
-973,710
| -40% | -$3.82M |
|
4
Palantir
PLTR
$372B
| $4.02M | 2.76% |
29,500
| – | – |
|
5
QuidelOrtho
QDEL
$1.95B
| $3.41M | 2.34% |
118,291
| – | – |
|
|
6
Teladoc Health
TDOC
$1.37B
| $3.32M | 2.28% |
381,000
-184,900
| -33% | -$1.61M |
|
7
Forian
FORA
$61.3M
| $2.68M | 1.84% |
1,366,107
| – | – |
|
8
CAVA Group
CAVA
$7.83B
| $1.57M | 1.07% |
18,600
| – | – |
|
9
Biogen
BIIB
$19.4B
| $303K | 0.21% |
2,412
| – | – |
|
10
Peloton Interactive
PTON
$3.1B
| – | – |
0
| – | – |
|
|
11
Recursion Pharmaceuticals
RXRX
$2.04B
| – | – |
-120,000
| Closed | -$635K |
|
|
SWTX
12
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-531,351
| Closed | -$23.4M |
|
13
Viking Therapeutics
VKTX
$3.04B
| – | – |
0
| – | – |
|
14
SPDR NYSE Technology ETF
XNTK
$1.25B
| – | – |
0
| – | – |
|